Cécile Goujard

Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)

Véronique Joly, Charles Burdet, Roland Landman et al. · Journal of Antimicrobial Chemotherapy · 2018 · 80 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Spontaneous Control of Viral Replication during Primary HIV Infection: When Is “HIV Controller” Status Established?

Cécile Goujard, Marie‐Laure Chaix, O. Lambotte et al. · Clinical Infectious Diseases · 2009 · 77 citations · Full text

Life Sciences, Infectious Diseases, Clinical Immunology +11

Pregnancy and contraception in a French cohort of HIV-infected women

Isabelle de Vincenzi, Corinne Jadand, Élisabeth Couturier et al. · AIDS · 1997 · 73 citations

Medicine, Maternal Health, Obstetrics +12

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial

Antoine Chéret, Georges Nembot, Adeline Mélard et al. · The Lancet Infectious Diseases · 2015 · 72 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study

Christine Katlama, Lambert Assoumou, Marc‐Antoine Valantin et al. · Journal of Antimicrobial Chemotherapy · 2019 · 37 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17